Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
0.420
-0.005 (-1.20%)
At close: Feb 21, 2025, 4:00 PM
0.402
-0.018 (-4.36%)
After-hours: Feb 21, 2025, 4:56 PM EST
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $17.35 million as of February 21, 2025. Its market cap has decreased by -88.58% in one year.
Market Cap
17.35M
Enterprise Value
-39.48M
1-Year Change
-88.58%
Ranking
Category
Stock Price
$0.42
Market Cap Chart
Since the IPO on October 9, 2020, Spruce Biosciences's market cap has decreased from $333.95M to $17.35M, a decrease of -94.81%. That is a compound annual growth rate of -49.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 17.35M | - |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | 564.33M | 68.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |